August 2019

Volume 27 Issue 8

Editorial Staff

Clinical Editor
Morton Kern, MD
Executive Editor
Laurie Gustafson
Managing Editor
Rebecca Kapur
Production Manager
Elizabeth Vasil

Editorial Correspondence

Rebecca Kapur, Managing Editor, Cath Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (440) 717-0418

Fax: (866) 896-8762
Treating end-stage peripheral arterial disease (PAD), better known as critical limb ischemia (CLI), is a daily challenge and requires what basketball player Kobe Bryant refers to as a persistent “Mamba Mentality”, defined as “constantly trying to be…
We should try to reduce contrast media in all patients and especially in those patients with impaired renal function, diabetes, or congestive heart failure.
“At the moment we don’t know why some patients react in this way. It is possibly linked to fear or anxiety. This should be a novel element in educating people about what to do when they have heart attack symptoms.”
Angiography revealed the patient to have an anomalous separate ostium of the right acute marginal artery, a finding that did not affect performance of the catheterization or patient outcome.
With CMS’ support of the safety and efficacy of diagnostic catheterizations in the ASC setting, the potential for PCI approval in the ASC can be reasonably anticipated within the next two to four years.
Percutaneous therapies for peripheral arterial disease (PAD) are continually evolving with advances in technology and experience.
There seems to be some sort of heterogeneity between the mortality risk and the baseline patient characteristics. We need to be able to explore this more thoroughly before we make any decisions about how to continue using paclitaxel. We need access t…
Since a large portion of my practice consists of patients with complex lesions, I have continued to use these devices extensively and will plan to continue using them as I currently do.
A premature form of mitral annular calcification occurs in patients with end-stage renal disease (ESRD) and prevalence is estimated to be as high as 40% in this cohort.(3)
This case adds insight into the benefit of complementary endovascular technologies with difficult vascular surgery to improve outcomes in complex peripheral vascular disease.